Proteon logo     Print Page | Close Window

SEC Filings

S-1
PROTEON THERAPEUTICS INC filed this Form S-1 on 09/16/2014
Entire Document
 

 

Series D Price” shall have the meaning set forth in Section 1.1(b) hereof.

 

Shares” shall mean, collectively, (i) any shares of Series D Preferred Stock or Common Stock sold or issued pursuant to this Agreement and (ii) any shares of Common Stock issued or issuable upon conversion of any shares of Series D Preferred Stock sold or issued pursuant to this Agreement.

 

Skyline IV” means Skyline Venture Partners Qualified Purchaser Fund IV, L.P.

 

Third Tranche Closing” shall have the meaning set forth in Section 1.2(c)(i) hereof.

 

Third Tranche Closing Notice” shall have the meaning set forth in Section 1.2(c)(i) hereof.

 

Third Tranche Individual Purchase Exercise Notice” shall have the meaning set forth in Section 2.1(b)(i) hereto.

 

Third Tranche Individual Purchase Right” shall have the meaning set forth in Section 2.1(b)(i) hereto.

 

Third Tranche Individual Purchase Shares” shall have the meaning set forth in Section 2.1(b)(i) hereto

 

Third Tranche Shares” shall have the meaning set forth in Section 1.1(d)(i) hereof.

 

Total Note Conversion Shares” shall have the meaning set forth in Section 1.1(b)(i) hereto.

 

Tranche Shares” shall mean, as of the relevant time of reference thereto, those shares of Series D Preferred Stock sold by the Company, and purchased by Purchasers, prior to such time pursuant to Section 1.1(b), Section 1.1(c) and/or Section 1.1(d) hereof, as applicable.

 

Transaction Agreements” means this Agreement, the Investors’ Rights Agreement, the Management Rights Letter, the Right of First Refusal and Co-Sale Agreement and the Voting Agreement.

 

TVM LSV VI GmbH” means TVM Life Science Ventures VI GmbH & Co. KG.

 

TVM LSV VI LP” means TVM Life Science Ventures VI, L.P.

 

Updated Disclosure Schedule” shall have the meaning set forth in Section 1.3 hereof.

 

15